Dermatological Safety of Chlorhexidine-Impregnated Dressings in Paediatric Intensive Care: A Randomised Clinical Trial.
Francisco Javier Portero-Prados, Manuel Pabón-Carrasco, José Antonio Ponce-Blandón
PMID 42360019WHAT IT FOUND
Skin lesions were not clearly different overall between PICU central line dressings.
Infants with chlorhexidine developed lesions much earlier. Catheter infections were lower, but that was a secondary outcome.
Key findings
01The primary outcome, skin lesions at the catheter insertion site, was not significantly different between chlorhexidine and conventional dressings.
02Skin lesions appeared at significantly younger ages in the chlorhexidine group.
03Catheter-related bloodstream infection was lower in the chlorhexidine group, but this was a secondary outcome.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study was done in one paediatric intensive care unit, so other units may not get the same results. Skin lesions were found by routine nursing observation, not a validated dermatological scale, so mild lesions may have been missed or classified differently. The trial was powered for the primary skin outcome, but the age interaction and infection reduction were secondary or exploratory questions. Only 35 children had skin lesions, so small differences in uncommon skin events could be missed.
Declared interests
The authors reported no conflicts. They stated that generative AI tools were used only for English language editing, and that all scientific content and final decisions were the authors'.
The easy way to misread this
Do not read the 18.4% versus 2.4% infection reduction as proof that chlorhexidine dressings prevent line infections. Infection was a secondary outcome, and the primary skin outcome did not show a clear difference.